Lorus Therapeutics Inc
LRUSF:OTCQB
| 最新 | 变化/%变化 | 股息收益率 | 交易量 | Avg Volume (10 day) |
| 0.277 | 0.00 0.00% | 0.00% | 0 | 243 |
Lorus Therapeutics Inc的最新新闻标题
- Lorus Therapeutics Announces Allowance of Chinese Patent for
Anticancer Drug LOR-253
Lorus Therapeutics Inc. (TSX: LOR) ("Lorus"), a biopharmaceutical company specializing in the discovery, research and development of pharmaceutical products and technologies for the management of cancer, today announced that Lorus' patent for its lead small molecule anticancer drug LOR-253 has been allowed in China. The patent provides Lorus with exclusive rights to LOR-253 in China until 2026.
- Lorus Therapeutics Announces Allowance of Chinese Patent for Anticancer Drug LOR-253
Lorus Therapeutics Inc. (TSX:LOR) ("Lorus"), a biopharmaceutical company specializing in the discovery, research and development of pharmaceutical products and technologies for the management of cancer, today announced that Lorus' patent for its lead small molecule anticancer drug LOR-253 has been allowed in China. The patent provides Lorus with exclusive rights to LOR-253 in China until 2026.
- Ubika Research's Daily Canadian Box Score: Top Junior Energy (TSX VENTURE: EM) Stock Gained 29%
TORONTO, Canada: In tracking the small cap stock universe of Canadian stocks based on proprietary criteria for Friday, February 15, 2013, Ubika Research found the top small cap stock gainers from each of the following sectors.
更多最新标题
没有数据